COMMUNIQUÉS West-GlobeNewswire

Misonix Reports Record Second Quarter Revenue
06/02/2018
FARMINGDALE, N.Y., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
TiGenix: Transparency Information
06/02/2018
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - February 6, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 [...]
Cerner Reports Fourth Quarter and Full Year 2017 Results
06/02/2018
KANSAS CITY, Mo., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced results for the 2017 fourth quarter and full year that ended December 30, 2017. Bookings in the fourth quarter of [...]
Diffusion Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference
06/02/2018
CHARLOTTESVILLE, Va., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test
06/02/2018
Curetis Unyvero HPN Application Receives Singapore Health Sciences Authority Approval; Updates on Sepsis Host Response Test Market authorization paves way for broader Unyvero commercial roll-out in ASEAN region through [...]
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
06/02/2018
Study successfully achieved both primary endpoints Second positive Phase 3 demonstrating the safety and efficacy of IMVAMUNE and final study required for licensure, as agreed with FDA BLA filing expected in second half [...]
It’s Time to Build an “Own the Podium” Program for Home Care in Canada, Says VHA Home HealthCare CEO Carol Annett
06/02/2018
TORONTO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- VHA Home HealthCare: Expectations are high for Canada’s medal performance at this month’s Winter Olympics in PyeongChang. After our impressive showing in Rio, which surpassed [...]
Lumere Names John Cherf, MD, MPH, MBA, as Its First-Ever Chief Medical Officer
06/02/2018
CHICAGO, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Lumere, the leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unnecessary clinical variation and costs, today announced the [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018
06/02/2018
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018
06/02/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]
VALNEVA : Déclaration d'actions et de droits de vote - Janvier 2018
06/02/2018
VALNEVA Déclaration d'actions et de droits de vote - JANVIER 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Poster presentation at WORLDSymposium™ 2018 – arimoclomol as clinical candidate for treatment of Gaucher disease
06/02/2018
Investor news Orphazyme A/S No. 02/2018 Copenhagen, February 6, 2018 – Orphazyme A/S , a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, today announced [...]
GW Pharmaceuticals to Present at the Leerink Partners 7th Annual Global Healthcare Conference on 14 February
06/02/2018
LONDON and CARLSBAD, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
V ClinBio Acquires 49.98% Stake in Cellix to Advance Synergix, a Transformative Pro-drug Technology Platform
06/02/2018
- Lead compounds for the treatment of relapsing-remitting multiple sclerosis and ulcerative colitis on target to enter clinic in 2018 - PRINCETON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- V ClinBio Inc., an innovative [...]
Aviragen Adjourns Special Meeting of Stockholders Until February 9, 2018
06/02/2018
ATLANTA, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) today announced that its Special Meeting of Stockholders, scheduled for and convened on February 6, 2018, has been adjourned to [...]
AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand
06/02/2018
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, announced today that it has entered into a binding distribution [...]
Xoc Pharmaceuticals Announces $30 Million Series A Financing Led by NEA
06/02/2018
LOS GATOS, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Xoc Pharmaceuticals, Inc., a privately-held, early-stage biopharmaceutical company focused on the development of innovative therapeutics for diseases of the central [...]
Sienna Announces Q4 2017 Results Release Date and Conference Call
06/02/2018
MARKHAM, Ontario, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA ) announced that it will report its 2017 fourth quarter results after market close on Thursday, [...]
Biothera Pharmaceuticals Commences Phase 2 Head and Neck Cancer Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA® (pembrolizumab)
06/02/2018
EAGAN, Minn., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. announced today that patient treatment has commenced in its Phase 2 clinical study in squamous cell carcinoma of the head and neck (SCCHN). [...]

Pages